iBio (AMEX:IBIO) reported quarterly losses of $(6.50) per share which beat the analyst consensus estimate of $(7.41) by 12.28 percent. The company reported quarterly sales of $225.000 thousand which beat the analyst consensus estimate of $25.000 thousand by 800.00 percent.
IBio FY 2024 GAAP EPS $(6.50) Beats $(7.41) Estimate, Sales $225.000K Beat $25.000K Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.